CN Patent

CN113214097B — 治疗阿尔茨海默病的化合物

Assigned to East China University of Science and Technology · Expires 2022-08-30 · 4y expired

What this patent protects

本发明提供式I所示化合物、其各种晶型、水合物、溶剂合物或药学上可接受的盐和药物组合物。本发明的化合物能够有效治疗阿尔茨海默病，特别是阿尔茨海默病所致认知功能损伤。

USPTO Abstract

本发明提供式I所示化合物、其各种晶型、水合物、溶剂合物或药学上可接受的盐和药物组合物。本发明的化合物能够有效治疗阿尔茨海默病，特别是阿尔茨海默病所致认知功能损伤。

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: CN113214097B
Jurisdiction: CN
Classification: —
Expires: 2022-08-30
Drug substance claim: No
Drug product claim: No
Assignee: East China University of Science and Technology
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.